Provider

The growth of telehealth and remote-monitoring tools could be a game-changer for women's health, particularly maternal and fetal care.

During a panel at CES, leaders at digital therapeutic companies discuss the state of the market right now and what’s needed to boost adoption.

Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.

This news comes after the FDA sent the company a warning letter regarding its smart socks. 

They plan to infuse AI, big data, and cloud technologies with digital therapeutics.

A postponed launch and technical hurdles have hampered the testing phase of digital prescriptions in Germany, and the country now enters a prolonged piloting phase at the start of 2022.

The company merge will further innovate digital healthcare in the UK.

According to a study published in JMIR, providers are generally positive about remote therapy and tele-rehabilitation, but they need more training and support to overcome obstacles like technology hurdles and practical concerns.

Researchers did not find a significant reduction in the rate of hospitalizations between participants in the standard care group and those in the digital intervention group. 

As another pandemic year ends, leaders in the digital health space reflect on what the industry has learned in 2021.